• Item 1
  • Item 2
  • Item 3
✕
  • Home
  • About us
    • About us
    • Our Mission
    • The team
    • Workshops
    • Research
    • Contact
  • R&I Rare Disease Genetics
    • R&I Rare Disease
    • Innovative solutions
    • Quality
    • Accessibility
  • Our Analyses
  • Transparency
  • Contact
  • it_ITItalian
R_I_rare_disease_logo_bn
  • Item 1
  • Item 2
  • Item 3
Ricerca Geni
✕
  • Screenshot 2024-09-11 alle 09.41.05Our Analyses
  • CardiologiaCardiology
  • DermatologiaDermatology
  • EmatologiaHaematology/Immunology
  • EndocrinologiaEndocrinology/Metabolism
  • GastroenterologiaGastroenterology
  • NefrologiaNephrology
  • NeurologiaCNS neurology
  • NeurologiaSNP neurology
  • OftalmologiaOphthalmology
  • OncologiaOncology
  • OtotinolaringoiatriaOtolaryngology
  • PneumologiaPneumology
  • sistema ScheletricoSkeletal System
✕
✕

Login

Lost your password?

0
0

0,00 €

Up to 20% off patio Shop now
Up to 60% off summer footwear See more
  • Screenshot 2024-09-11 alle 09.41.05Our Analyses
  • CardiologiaCardiology
  • DermatologiaDermatology
  • EmatologiaHaematology/Immunology
  • EndocrinologiaEndocrinology/Metabolism
  • GastroenterologiaGastroenterology
  • NefrologiaNephrology
  • NeurologiaCNS neurology
  • NeurologiaSNP neurology
  • OftalmologiaOphthalmology
  • OncologiaOncology
  • OtotinolaringoiatriaOtolaryngology
  • PneumologiaPneumology
  • sistema ScheletricoSkeletal System
Up to 20% off patio Shop now
Up to 60% off summer footwear See more
Click here
  • Screenshot 2024-09-11 alle 09.41.05Our Analyses
  • CardiologiaCardiology
  • DermatologiaDermatology
  • EmatologiaHaematology/Immunology
  • EndocrinologiaEndocrinology/Metabolism
  • GastroenterologiaGastroenterology
  • NefrologiaNephrology
  • NeurologiaCNS neurology
  • NeurologiaSNP neurology
  • OftalmologiaOphthalmology
  • OncologiaOncology
  • OtotinolaringoiatriaOtolaryngology
  • PneumologiaPneumology
  • sistema ScheletricoSkeletal System
Search for a test
R_I_rare_disease_logo_bn
Medical Area
  • Home
  • About us
    • About us
    • Our Mission
    • The team
    • Workshops
    • Research
    • Contact
  • R&I Rare Disease Genetics
    • R&I Rare Disease
    • Innovative solutions
    • Quality
    • Accessibility
  • Our Analyses
    • OUR ANALYSES
    • CardiologiaCardiology
    • DermatologiaDermatology
    • EmatologiaHaematology/Immunology
    • GastroenterologiaGastroenterology
    • NefrologiaNephrology
    • EndocrinologiaEndocrinology/Metabolism
    • NeurologiaCNS neurology
    • NeurologiaSNP neurology
    • OftalmologiaOphthalmology
    • OncologiaOncology
    • OtotinolaringoiatriaOtolaryngology
    • PneumologiaPneumology
    • sistema ScheletricoSkeletal System
  • Transparency
  • Contact
  • it_ITItalian

  

  • Home
  • Search Genes

Filter by clinical area:

Cardiology

Dermatology

Haematology/ Immunology

Gastroenterology

Nephrology

Endocrinology/ Metabolism

CNS neurology

SNP neurology

Ophthalmology

Oncology

Otolaryngology

Pneumology

Skeletal System


230 products available


R-158S245

Distal renal tubular acidosis

 


5 genes

R-158S246

Generalised and proximal renal tubular acidosis

 


9 genes

R-196S290

Acromatopsia

 


7 genes

R-178

Agenesis - dysplasia of the corpus callosum

 


445 genes

R-206

Oculocutaneous albinism

 


26 genes

R-118S218

Alpha Thalassaemia (HBA1 and HBA2)

 


2 genes

R-196S291

Leber's congenital amaurosis

 


27 genes

R-141

Primary amenorrhoea

 


145 genes

R-103

Familial amyloidosis (TTR)

 


1 gene

R-118

Haemolytic anaemia extended analysis

 


66 genes

R-176S259

Cerebral amyloid angiopathy (CAA)

 


8 genes

R-218

Aortopathies

 


34 genes

R-101

Arrhythmias extended analysis

 


75 geniuses

R-101S201

Ventricular arrhythmias

 


43 genes

R-217

Arthrogryposis

 


155 genes

R-177S266

Episodic ataxia

 


9 genes

R-177

Ataxia extended analysis

 


136 genes

R-177S267

Spastic ataxia

 


6 genes

R-208

Optic atrophy extended analysis

 


16 genes

R-120S223

Self-inflammation

 


70 genes

R-216S295

Brachydactyly

 


23 genes

R-144

Short stature

 


421 genes

R-118S219

Beta Thalassaemia (HBB)

 


1 gene

R-162

CAKUT (Congenital Abnormalities of the Kidney and Urinary Tract)

 


91 genes

R-102S209

Arrhythmogenic cardiomyopathy

 


19 genes

R-102S207

Non-syndromic dilated cardiomyopathy

 


58 genes

R-102S307

Syndromic dilated cardiomyopathy

 


20 genes

R-102S208

Non-syndromic hypertrophic cardiomyopathy

 


34 genes

R-102S308

Syndromic hypertrophic cardiomyopathy

 


23 genes

R-102S210

Restrictive cardiomyopathy

 


16 genes

R-102

Cardiomyopathies extended analysis

 


117 genes

R-106S309

Non-syndromic heart disease

 


56 genes

R-106S310

Syndromic heart disease

 


104 genes

R-198

Congenital cataract

 


34 genes

R-196S292

Stationary night blindness

 


16 genes

R-182

Ceroidolipofuscinosis

 


15 genes

R-111

Palmoplantar keratoderma

 


28 genes

R-138

Chylomicronemia

 


4 genes

R-188

Ciliopathies extended analysis

 


146 genes

R-158S243

Cystinuria

 


2 genes

R-152

Cholelithiasis

 


3 genes

R-145S233

Familial intrahepatic cholestasis

 


7 genes

R-145

Cholestasis extended analysis

 


37 genes

R-107S215

Collagenopathies with vascular involvement

 


35 geniuses

R-107

Collagenopathies extended analysis

 


109 genes

R-202

Coloboma, anophthalmia and microphthalmia

 


86 genes

R-184S268

Korea

 


18 genes

R-216S302

Craniosynostosis

 


106 genes

R-136

Vitamin B12 deficiency

 


17 genes

R-176S262

Lysosomal storage dementia

 


12 genes

R-176S263

Frontotemporal dementia

 


16 genes

R-176S260

Familial vascular dementia

 


4 genes

R-176

Dementias extended analysis

 


64 genes

R-125S225

Childhood-onset diabetes

 


34 genes

R-125S228

Diabetes at neonatal onset

 


23 genes

R-125S226

Insulin-resistant diabetes

 


27 genes

R-125

Diabetes extended analysis

 


66 genes

R-123

Diamond-Blackfan Anaemia

 


22 genes

R-151

Congenital diarrhoea

 


33 genes

R-106

Heart disease extended analysis

 


211 genes

R-118S217

Red blood cell enzyme defects and related metabolic disorders

 


21 genes

R-145S232

Defects in bile acid conjugation and transport

 


4 genes

R-119S221

Defects in platelet function

 


21 genes

R-145S231

Defects in bile acid synthesis

 


7 genes

R-188S303

Primary ciliary dyskinesia

 


47 genes

R-201

Dysgenesis of the anterior segment of the eye

 


36 genes

R-126

Dyslipidaemia extended analysis

 


27 genes

R-166

Hepatorenal cystic disorders

 


88 genes

R-119S220

Coagulation factor disorders

 


24 genes

R-175

Disorders of small cerebral vessels - stroke

 


32 genes

R-128

Sexual differentiation disorders

 


52 genes

R-184

Extrapyramidal movement disorders extended analysis

 


137 genes

R-169

Neurodevelopmental disorders

 


1702 genes

R-119

Coagulation and platelet disorders extended analysis

 


98 genes

R-137

Glycosylation disorders

 


161 genes

R-135

Lysosomal disorders

 


95 genes

R-185

Paroxysmal movement disorders

 


68 genes

R-134

Peroxisomal disorders

 


30 genes

R-219

Ectodermal dysplasia

 


59 genes

R-216S296

Bone dysplasias / dysostoses

 


163 genes

R-184S269

Dystonia

 


43 genes

R-191S280

Caterpillar dystrophy

 


33 genes

R-196S293

Cones and rods dystrophy

 


37 genes

R-199

Corneal dystrophies

 


14 genes

R-191S306

Muscular dystrophies

 


36 genes

R-196

Non-syndromic retinal dystrophies extended analysis

 


166 genes

R-207

Ectopia lentis

 


18 genes

R-26S301

Ectrodactyly

 


8 genes

R-186

Monogenic migraine

 


15 genes

R-146

Haemochromatosis

 


7 genes

R-170S249

Glycine encephalopathy

 


4 genes

R-170S248

Epileptic encephalopathy

 


105 genes

R-108

Epidermolysis bullosa

 


20 genes

R-170S247

Benign neonatal epilepsy

 


5 genes

R-170S252

Temporal lobe epilepsy

 


4 genes

R-170S255

Pyridoxine-dependent epilepsy

 


4 genes

R-170S250

Febrile epilepsy

 


8 genes

R-170S251

Focal epilepsy

 


26 genes

R-170S253

Myoclonic epilepsy

 


34 genes

R-170S254

Nocturnal epilepsy

 


5 genes

R-170

Syndromic and non-syndromic epilepsy extended analysis

 


1061 genes

R-124

Erythrocytosis and polyglobulia

 


13 genes

R-100

Heterotaxy

 


51 genes

R-171

Periventricular nodular heterotopia

 


55 genes

R-156

Polycystic liver

 


7 genes

R-211

Paraganglioma pheochromocytoma

 


29 genes

R-101S200

Atrial fibrillation

 


43 genes

R-147

Hepatic fibrosis

 


104 genes

R-214

Pulmonary fibrosis

 


37 genes

R-196S286

Fundus albipunctatus, retinitis punctata albescens

 


4 genes

R-176S258

Basal ganglia: ganglion degeneration

 


3 genes

R-200

Congenital glaucoma

 


43 genes

R-192

Glycogenosis

 


26 genes

R-158S241

Renal glycosuria

 


3 genes

R-120

Immunodeficiency and autoinflammation extended analysis

 


331 genes

R-115

Incontinentia pigmenti (IKBKG)

 


1 gene

R-149

Early onset intestinal inflammation (VEO-IBD)

 


100 genes

R-154

Acute childhood liver failure

 


7 genes

R-168

Overgrowth

 


112 genes

R-153

Hyperbilirubinemia

 


4 genes

R-129

Hypercalcaemia

 


21 genes

R-126S229

Familial hypercholesterolaemia

 


4 genes

R-132

Hyperphenylalaninemia

 


13 genes

R-131

Hyperinsulinism

 


34 genes

R-158S244

Primary hyperoxaluria

 


3 genes

R-133

Hyperparathyroidism

 


10 genes

R-142

Classical congenital adrenal hyperplasia due to 21-hydroxylase (CYP21A2) deficiency

 


1 gene

R-148

Hypertransaminasemia

 


232 genes

R-159

Hyperuricaemia

 


14 genes

R-213

Non-syndromic hypoacusis

 


107 genes

R-143

Hypobeta-abeta-lipoproteinemia

 


4 genes

R-130

Hypoglycaemia

 


76 genes

R-140

Hypogonadism and Kallmann syndrome

 


68 genes

R-158S239

Hypomagnesemia

 


7 genes

R-179

Cerebellar hypoplasia

 


127 genes

R-109

Ichthyosis

 


27 genes

R-176S261

Adult-onset leukodystrophy

 


9 genes

R-172

Leukodystrophy and leukoencephalopathy

 


422 genes

R-173

Lissencephaly

 


0 genes

R-176S265

Alzheimer's disease

 


4 genes

R-104

Fabry disease (GLA)

 


1 gene

R-176S264

Niemann-Pick disease type C (NPC1 and NPC2)

 


2 genes

R-196S287

Stargardt's disease and macular dystrophies

 


20 genes

R-187

Motor neuron diseases extended analysis

 


145 genes

R-163

Tubulo-interstitial diseases

 


6 genes

R-183

Cortical malformations

 


195 genes

R-216

Skeletal malformations extended analysis

 


447 genes

R-174

Microcephaly

 


224 genes

R-194

Facio-scapulohumeral myopathy type 1

 


1 gene

R-195

Facio-scapulohumeral myopathy type 2

 


1 gene

R-191S281

Congenital myopathies

 


46 genes

R-191S279

Distal myopathies

 


31 genes

R-191S282

Metabolic and mitochondrial myopathies

 


69 genes

R-191

Myopathies extended analysis

 


210 genes

R-193

Dystrophic myotonia type 1, search for DMPK expansions

 


1 gene

R-191S284

Non-dystrophic myotonia

 


8 genes

R-180

Mitochondriopathies (nuclear genes)

 


266 genes

R-125S224

MODY maturity-onset diabetes of the young

 


15 genes

R-113

Monilethrix

 


4 genes

R-216S297

Primordial dwarfism

 


18 genes

R-160

Nephrocalcinosis and nephrolithiasis

 


42 genes

R-158S242

Nephrolithiasis

 


3 genes

R-188S304

Nephronophthisis

 


22 genes

R-212

Multiple endocrine neoplasia

 


12 genes

R-176S257

Neurodegeneration with iron accumulation

 


15 genes

R-116

Neurofibromatosis (NF1 and NF2)

 


2 genes

R-208S94

Leber's optic neuropathy

 


0 genes

R-190

Sensory autonomic neuropathies

 


19 genes

R-187S273

Distal motor neuropathy and SMA

 


42 genes

R-189S278

Sensorimotor neuropathies: Axonal, demyelinating and intermediate CMTs

 


66 genes

R-189

Sensory-motor and distal neuropathies extended analysis

 


93 genes

R-197

Congenital nystagmus

 


329 genes

R-102S206

Non-compaction left ventricle

 


37 genes

R-127

Non-syndromic obesity

 


19 genes

R-216S298

Osteogenesis imperfecta

 


40 genes

R-216S299

Osteopetrosis

 


30 genes

R-150

Pancreatitis

 


5 genes

R-191S285

Periodic paralysis

 


8 genes

R-187S272

Spastic paraplegia

 


84 genes

R-184S270

Parkinsonism

 


37 genes

R-205

Piebaldism

 


2 genes

R-216S300

Polydactyly / syndactyly / triphalangism

 


23 genes

R-139

Porphyria

 


10 genes

R-157

Proteinuria extended analysis

 


160 genes

R-110

Elastic pseudoexantoma

 


5 genes

R-167

Pseudoipoaldosteronism

 


10 genes

R-158S240

Hypophosphatemic rickets

 


8 genes

R-215

Vitamin D dependent rickets

 


3 genes

R-105

Rasopathies and Noonan syndrome

 


39 genes

R-164

Dominant polycystic kidney

 


8 genes

R-165

Polycystic kidney dominant (PKD1 and PKD2)

 


2 genes

R-196S288

Retinitis pigmentosa

 


86 genes

R-187S271

Amyotrophic lateral sclerosis (ALS)

 


50 genes

R-117

Tuberous sclerosis (TSC1 and TSC2)

 


2 genes

R-118S216

Spherocytosis, Ellipsocytosis and Stomatocytosis, defects in the membrane and cytoskeleton of red blood cells

 


22 genes

R-101S202

Short QT syndrome

 


8 genes

R-102S203

Long QT syndrome

 


22 genes

R-145S230

Alagille syndrome - paucity of bile ducts

 


2 genes

R-157S213

Alport syndrome

 


3 genes

R-188S274

Bardet-Biedl syndrome

 


24 genes

R-158S235

Bartter's syndrome

 


7 genes

R-101S204

Brugada Syndrome

 


40 genes

R-155

Coach Syndrome

 


3 genes

R-158S236

Dent's syndrome

 


2 genes

R-170S256

Doose Syndrome

 


9 genes

R-107S211

Ehlers-Danlos syndrome

 


56 genes

R-158S238

Gitelman syndrome

 


2 genes

R-158S237

Gordon syndrome, familial hypertension with hyperkalemia

 


8 genes

R-188S305

Jeune and short rib syndromes

 


20 genes

R-188S275

Joubert's syndrome

 


40 genes

R-107S212

Marfan syndrome

 


21 genes

R-188S276

Meckel's syndrome

 


15 genes

R-188S277

Senior Loken Syndrome

 


10 genes

R-107S214

Stickler syndrome

 


5 genes

R-203

Usher Syndrome

 


20 genes

R-204

Waardenburg Syndrome

 


7 genes

R-191S283

Myasthenic syndrome

 


28 genes

R-157S234

Corticoresistant nephrotic syndrome

 


59 genes

R-112

Peeling skin syndrome

 


10 genes

R-161

Haemolytic uremic syndrome

 


17 genes

R-121

Vexas syndrome (UBA1)

 


1 gene

R-181

Mitochondrial DNA depletion syndromes (nuclear genes)

 


34 genes

R-101S205

Catecholaminergic polymorphic ventricular tachycardia

 


12 genes

R-122

Hemorrhagic telangiectasia

 


6 genes

R-119S222

Thrombocytopenia

 


65 genes

R-158

Tubulopathies extended analysis

 


88 genes

R-209

Hereditary breast and ovarian cancer (BRCA1 and BRCA2)

 


2 genes

R-210

Hereditary tumours

 


113 genes

R-196S289

Vitreoretinopathy

 


14 genes

R-114

Xeroderma pigmentosum

 


23 genes

×

Download documentation

To access the analyses, it is necessary to fill in the specific downloadable forms, after reading the appropriate information:


Adult analysis request form + informed consent
Minor analysis request form + informed consent
Trio/duo analysis request form + informed consent
Sample preparation and shipment
R_I_rare_disease_logo_bn

Laboratory specialising in medical genetics

Technical Director: Dr. Alice Bruson Data Protection Manager : Andrea Orsi

Contact

+39 049-8705062

800-031666

info@rigenetics.com

Where we are

Research Tower
C.so Stati Uniti, 4
35127 Padua

Link

Work with us 

Privacy & Cookie Policy

Appreciation

© 2025 R&I Genetics Srl | P.Iva 04180510283 | All rights reserved

✕
 
Sample preparation

The sample of choice is blood.

Two purple cap tubes (K2DTA) with 4-5 ml of blood each for the adult or 1-2 ml for the child are sufficient.

  • Store at +4 degrees until dispatched; DO NOT FREEZE

  • Ship the sample at room temperature in the appropriate containers within 2-3 days.

  • The sample must arrive at the laboratory within 4 days​​

R&I Genetics can send doctors e-mails upon request info@rigenetics.comcomplete blood sampling kits, including shipping envelope.

The kit can be picked up at the address communicated by e-mail to info@rigenetics.com by a courier at R&I Genetics' expense.

✕

 

Reporting

The report will be available within 8-12 weeks after receipt of the sample for gene panel and single gene analysis; for exome or trio genome analysis the report will be available within 12-20 weeks.

The original report will be sent by courier to the requesting doctor and will be available and downloadable from the reserved area of our site by the same doctor.

R&I Genetics will keep the requesting physician informed of the analysis process by e-mail.

✕

Our analyses

R&I Genetics is a laboratory accredited with the National Health System specialising in the diagnosis of hereditary diseases, both rare and common.

We offer a full range of genetic analyses, ranging from single gene analysis to gene panels to exome and genome sequencing.

R&I Genetics actively collaborates with leading Italian hospital and university centres, guaranteeing a high level of expertise and support in genetic diagnosis.

 

✕

Technology

R&I Genetics uses Next Generation Sequencing (NGS) as well as CGH analysis, Sanger sequencing, MLPA analysis, to analyse patients' DNA. The identification of disease-causing variants can lead to a diagnosis, determine prognosis and help select the most appropriate treatments as well as define the risk of familial recurrence.

NGS technology enables an in-depth analysis of thousands of clinically relevant genes in a timeframe that facilitates clinical action and the possibility of performing almost all in-depth laboratory diagnostics, making R&I Genetics a benchmark for the diagnosis of rare genetic diseases.

✕

Innovative solutions

R&I Genetics offers a complete service of NGS (Next Generation Sequencing), CGH, MLPA, TP-PCR, QF-PCR and Sanger genetic testing performed entirely in its own laboratories, capable of meeting all clinical needs in the field of genetics.

R&I Genetics has been operating in Italy for over 20 years and has developed a unique know-how in the diagnosis of rare diseases with the creation of proprietary genotype-phenotype association databases that increase the diagnostic sensitivity of the tests offered.

R&I Genetics offers a complete service that includes sample analysis and, if necessary, sample collection, interpretation of variants, segregation in family members, preparation of the report with database and literature references, and electronic and paper submission of the report to the requesting physician.

R&I Genetics offers a technical support service to applicant doctors with trained operators.

✕

Method of analysis

R&I Genetics uses next-generation sequencing (NGS) to analyse the DNA of patients. Alterations in the DNA sequence (called variants) can be harmful and cause serious medical conditions. Many inherited diseases are caused by DNA variants that originate in germ cells and are subsequently present in all cells of the human body. 

The identification of disease-causing variants can lead to a diagnosis, determine a patient's prognosis and help select the most appropriate treatments.

NGS technology enables a comprehensive analysis of thousands of clinically relevant target genes in a timeframe that facilitates clinical intervention. NGS sequencing detects different types of variants, such as nucleotide substitutions (point mutations) or nucleotide addition/removal (insertions and deletions). R&I Genetics has also implemented NGS searches for genetic events called 'copy number variations' (CNVs), i.e. deletions or insertions of nucleotide portions of significant size (often one or more exons) that cannot be detected by traditional methods.

R&I Genetics offers a complete service of complementary genetic testing such as CGH array, MLPA, TP-PCR, QF-PCR and Sanger sequencing, all performed entirely in its own laboratories, capable of meeting all clinical needs in the genetic field.

✕

Bioinformatics process

Analysing data from NGS sequencing is a complex process that requires IT and human resources, such as processing servers and specialised personnel, as well as advanced software. The automated and proprietary bioinformatics pipeline developed and used by R&I Genetics enables rapid, reliable and highly accurate results.

The bioinformatics analysis adopted, developed and validated by R&I Genetics, is based on the Broad Institute's BWA-GATK pipeline but with more efficient calculation algorithms and an enterprise-level software implementation provided by Sentieone/o Dragen.

In addition to incorporating state-of-the-art algorithms for quality control, alignment and variant calling, the pipeline also employs filtering steps to remove common variants based on allele frequencies in population cohorts. Furthermore, the functional consequence of amino acid changes is predicted using several in silico tools, increasing the accuracy in identifying potentially pathogenic variants.

To further support the variant interpretation process, results are compared to a comprehensive set of disease-related mutation databases, collected and curated in-house, as well as databases accessible from public sources or licensed from commercial vendors. In summary, our bioinformatics pipeline is designed to provide our requesting physicians with complete and accurate information in the shortest possible time.

✕

Interpretation

The final step in the analysis process is the interpretation of data and classification of variants. R&I Genetics' interpretation strategy consists of exome sequencing and the use of internally developed gene panels (virtual gene sets), which are targeted, in relation to the clinical phenotype, to search for variants in genes that may be the cause of a given genetic disease. The effectiveness of gene panels depends on the choice of genes and the construction strategy adopted.

The genes included in the different panels are chosen following a thorough analysis of the scientific literature and a detailed system based on the association of possible clinical phenotypes to different diseases and underlying molecular mechanisms developed by the R&I Genetics R&D team.

The panel construction strategy involves, where possible, specific sub-systems of genes that identify, for example, specific pathologies in correlation with each other according to hierarchical interactions.

In a diagnostic context, variant classification is essential for making informed clinical decisions. Proper classification of variants is crucial for proper patient management and obtaining the best possible results. Without a thorough interpretation and evaluation of sequencing data, the results of genomic analysis risk being meaningless.

R&I Genetics has developed a variant classification scheme that follows the guidelines and interpretation criteria established by the American College of Medical Genetics and Genomics (ACMG 2015, 2017 and subsequent supplements), the industry standard for clinical genetic diagnostic laboratories.

Our interpretation schemes have been validated with tens of thousands of rare disease patients. Variants are evaluated using population and gene/disease-specific databases, R&I Genetics' proprietary internal variant database, numerous public and commercial mutation databases, and the appropriate scientific literature. The patient's medical history and any identified variants are reviewed together with the relevant medical and genetic literature.

✕

The Report

The report, which is delivered exclusively to the requesting specialist physician, contains all the information that enables the clinician to interpret and evaluate the genetic data.

The results related to the clinical question are reported in the 'Primary outcome' section, followed by a technical commentary, analysis of the most significant literature and classification of variants according to ACMG.

In the 'Secondary result' section, any variants indicating the proband's carrier status are reported, which is very important for the patient's family.

Finally, the report contains all the genes analysed and the relevant technical analytical information to guarantee the quality level of the analysis conducted.